Showing all 4 results
Clopidogrel & Aspirin Capsules
FreeClopidogrel and Aspirin capsules are a combination of two antiplatelet medications (blood thinners) used primarily to prevent heart attacks and strokes in patients with high cardiovascular risk.
Clopidogrel, Aspirin Tablets Clopidogrel, Aspirin Tablets
FreeA Clopidogrel + Aspirin tablet is a dual antiplatelet therapy (DAPT) used primarily to prevent serious cardiovascular events like heart attacks and strokes
Prasugrel Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips containing dedicated desiccants to ensure the absolute chemical stability of the highly volatile thienopyridine molecule.
Active Ingredient Strength Primary Clinical Function Prasugrel HCl INN/Ph.Eur. 5 mg Dose-Adjusted Standard: Maintenance dose strictly for vulnerable patients weighing < 60 kg or aged ≥ 75 years to minimize fatal bleeding risk. Prasugrel HCl INN/Ph.Eur. 10 mg Global Clinical Standard: Standard adult maintenance dose following a 60 mg acute loading dose in the Cath Lab. Excipients Microcrystalline Cellulose / Mannitol / Croscarmellose Sodium / Hypromellose / Triacetin Diluent / Superdisintegrant / Moisture-Barrier Film-Coating (Engineered specifically to prevent hydrolytic degradation and ensure ultra-fast gastric release) *Pack Sizes: 10×10 Alu-Alu Blisters or 28/30-Tablet Calendar Blisters (Optimized specifically for strict 12-month post-PCI dual-antiplatelet dispensing regimens).
Ticagrelor Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the highly sensitive active pharmaceutical ingredient across all global climate zones.
Active Ingredient Strength Primary Clinical Use Ticagrelor INN/Ph.Eur. 90 mg Acute & Post-ACS: Standard twice-daily dose for the first 12 months following a heart attack or stent placement. Ticagrelor INN/Ph.Eur. 60 mg Extended Maintenance: Long-term prophylaxis for high-risk patients continuing therapy beyond the initial 12-month period. Excipients Mannitol / Dibasic Calcium Phosphate / Sodium Starch Glycolate / Hypromellose Diluent / Superdisintegrant / Film Coating (Engineered for immediate, highly predictable gastric dissolution)
